BECTON DICKINSON & CO — Director's Dealing 2019

Dec 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2019-12-16

Reporting Person: Mas Ribo Alberto (EVP and Pres, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-16	Common Stock	M	12153	$134.73	Acquired	27739	Direct
2019-12-16	Common Stock	D	6068	$269.51	Disposed	21671	Direct
2019-12-16	Common Stock	S	11860	$269.51	Disposed	9811	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-16	Stock Appreciation Rights	$134.73	M	12153	Disposed	2024-11-25	Common Stock (12153)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2554	Indirect
Common Stock	1080	Indirect

Footnotes

F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $268.46 through $270.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Certain of the reported transactions were made pursuant to a 10b5-1 plan entered into on December 4, 2018.

F2: Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of May 31, 2019.

F3: Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of May 31, 2019.

F4: The stock appreciation rights vest in four annual installments beginning November 25, 2015.